noom microdose glp 1 Microdosing meets weight loss as turns a DIY trend into a medical program Noom shifts GLP-1 strategy toward

[DOI] [PMC free article] [PubMed] [Google Scholar] 65.Botfield HF, Uldall MS, Westgate CSJ, Mitchell JL, Hagen SM, Gonzalez AM, et al

GLP-1 agonist benefits to consider For those who are at greater risk of cardiovascular issues, some of the GLP-1 receptor agonists have shown cardiovascular benefits or a neutral cardiovascular profile

Common Side Effects (usually in the first weeks): Nausea The most common side effect

Sanyal, P

Recent News Reports Linking Ozempic Usage to Gastroparesis August 2025: Although many news reports and scientific studies have linked Ozempic to gastroparesis and delayed stomach emptying, the judge overseeing the lawsuit (MDL No

Related Stories Why new Alzheimers drugs are dividing regulators worldwide Scientists discover 70 existing drugs that block deadly hantavirus infections Semaglutide outperforms other GLP-1 drugs for weight loss in psychiatric populations Preclinical studies, small controlled trials, and observational research further suggest that GLP-1 receptor agonists may have beneficial effects in the prevention and treatment of mood disorders and in psychopathology domains that substantially impair quality of life, including cognitive dysfunction and anhedonia